Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL, by Baxter, Recalled: AttorneyOne Monitors and Keeps Consumers Informed

Share Article

On November 21, the US FDA announced that one lot of Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter International Inc., is recalled due to mislabeled overpouch. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers.

Highly Concentrated Potassium Chloride Injection Recalled

Highly Concentrated Potassium Chloride Injection Recalled

we are determined to keep an eye on FDA announcements concerning Highly Concentrated Potassium Chloride Injection

AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Highly Concentrated Potassium Chloride Injection.

The US FDA announced on November 21, that one lot of Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter International Inc., is recalled due to mislabeled overpouch. Potassium Chloride is administered intravenously and it is used to treat potassium deficiency.

The reason for the recall is based on a complaint of mislabeling. Some containers of Product Code 2B0826, Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL, Lot Number P319160, Exp. 06/30/2015, NDC 0338-0709-48 were incorrectly labeled on the overpouch as Highly Concentrated Potassium Chloride Injection, 20 mEq per 100 mL.

Use of the mislabeled overpouch may result in the administration of a dose lower than intended. In case of patients prone to severe electrolyte imbalance this may lead to serious, life-threatening, adverse consequences.

Taking into consideration the latest developments, AttorneyOne.com monitor daily and update the website providing accurate information on all relevant FDA safety alerts. Sean Burke, director of Media Relations at AttorneyOne.com, adds “we are determined to keep an eye on FDA announcements concerning Highly Concentrated Potassium Chloride Injection and inform the public. For that reason", he continues, "our focus should squarely fall on investigating these safety alerts and getting the word out.”

According to the announcement “Baxter has notified customers, who are being directed not to use product from the recalled lot.” And the announcement continues “Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to using this drug product.”

AttorneyOne.com has further information on Highly Concentrated Potassium Chloride Injection at the website including the latest major drug, food, and medical products law news.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2014/09/prweb12348385.htm

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Sean Burke
Attorney One
+1 877-230-7343
Email >
@Attorney_One
Follow >
Visit website